跳至主要内容
临床试验/NCT01672320
NCT01672320撤回不适用

Outcomes of Robotic Total Hip Arthroplasty: A Prospective Study

Massachusetts General Hospital1 个研究点 分布在 1 个国家开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Adverse Events

研究概览

简要总结

The objectives of this study are to evaluate the clinical value of robotic-assisted total hip arthroplasty with respect to acetabular cup implantation, and to document the long-term clinical outcome of patients with Total Hip Arthroplasty (THA). IRB approval will be obtained at every study site to evaluate the basic clinical outcomes and post-operative component placement accuracy of each MAKO® THA patient.

The hypothesis is that robotic preparation of the acetabulum will significantly reduce the variability and inaccuracy in the component alignment parameters that lead to post-operative complications, including implant failure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • 20 to 75 years of age
  • Subjects requiring primary total hip replacement
  • Contralateral hip should be relatively free from arthritis for comparison purposes, specifically with less than a grade of 2 on the Kellgren-Lawrence Scale.
  • Subjects diagnosed with osteoarthritis or traumatic arthritis
  • Subjects with avascular necrosis
  • Subjects who demonstrate the ability to return for follow-up for the next 10 years

排除标准

  • Subjects with difficulty understanding protocol for any reason
  • Subjects with a limited life span
  • Subjects with inflammatory hip disease, previous joint infection, or those requiring hip revision surgery
  • Female subjects who are pregnant, or who plan to get pregnant while enrolled in the study

结局指标

主要结局

Adverse Events

时间窗: 10 Years

Protocol deviations, complications, "lost to follow-up"

Survivorship of Components

时间窗: 10 Years

Defined as implant remaining in subject.

次要结局

  • Retrieval Analysis of implants from revision surgery(Up to 10 Years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Charles R. Bragdon

Research Scientist

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验